Artificial Intelligence in Pharmaceutical Research: Transforming Drug Discovery, Natural Product Screening, and Therapeutic Development

Abstract

Artificial intelligence (AI) has emerged as a transformative technology in pharmaceutical research by improving the efficiency, accuracy, and speed of drug discovery and therapeutic development processes. Traditional pharmaceutical development involves extensive experimental procedures, high costs, and long timelines, which often limit the identification and optimization of new therapeutic candidates. AI-driven approaches provide advanced computational strategies for analysing complex biological datasets, predicting molecular interactions, identifying promising drug candidates, and accelerating decision-making processes.

Machine learning, deep learning, natural language processing, and predictive modelling have become important components of modern pharmaceutical research. These technologies enable researchers to analyse chemical structures, predict drug–target interactions, evaluate pharmacokinetic properties, and optimize therapeutic molecules. AI-based platforms have also expanded opportunities in natural product screening by facilitating the identification of bioactive compounds, predicting biological activities, and supporting the discovery of plant-derived therapeutic agents.

The integration of artificial intelligence with pharmaceutical sciences has contributed to advancements in precision medicine, drug repurposing, personalized pharmacotherapy, and clinical development strategies. AI algorithms can process large-scale genomic, proteomic, metabolomic, and clinical datasets to identify disease mechanisms and develop patient-specific treatment approaches. Furthermore, AI-assisted computational models reduce experimental workload and support more efficient resource utilization during drug development.

Despite its significant potential, AI implementation in pharmaceutical research faces several challenges, including data quality limitations, algorithm transparency, regulatory concerns, computational requirements, and the need for interdisciplinary expertise. Addressing these issues is essential for ensuring reliable and ethical application of AI technologies in healthcare.

This review explores the role of artificial intelligence in pharmaceutical research, focusing on its applications in drug discovery, natural product screening, molecular analysis, and therapeutic development. The challenges, future opportunities, and emerging directions of AI-driven pharmaceutical innovation are also discussed. The integration of AI with advanced biological technologies is expected to reshape the future landscape of medicine by enabling faster, safer, and more personalized therapeutic solutions.